Scott Jennings
Papers
1
Total Citations
14
H-Index
1
About
Dr. Scott Jennings is a pioneering urologic oncologist whose research focuses on the application of advanced radiation technologies in the treatment of genitourinary malignancies, particularly renal cell carcinoma. His most cited work, a 2019 single-institution study on nephron-sparing robotic radiosurgical therapy for primary renal cell carcinoma, represents a significant contribution to the growing field of stereotactic body radiation therapy (SBRT) for kidney cancer. In this landmark paper, Dr. Jennings and his team prospectively evaluated 21 patients with stage I renal tumors, including 14 surgical candidates who declined surgery, demonstrating that SBRT can achieve effective tumor control while preserving renal function and minimizing toxicity. With 14 citations, this work has helped establish SBRT as a viable, non-invasive alternative for patients who are poor surgical candidates or who refuse nephrectomy. Dr. Jennings’ research bridges the gap between surgical oncology and radiation oncology, offering patients a nephron-sparing option that reduces morbidity. His contributions are particularly impactful for elderly or comorbid patients, expanding the therapeutic landscape for early-stage kidney cancer. Through his innovative work, Dr. Jennings continues to shape the future of minimally invasive, organ-preserving cancer care.
Research Focus
Key Achievements
Top Papers
- 1